Clinical ink
Winston-Salem, US · Founded 2013 · Delaware corporation · 3 known investors
Digital data collection and clinical trial technology platform offering Direct Data Capture, eCOA, eConsent, and digital biomarkers.
Founders & leadership
Clinical ink was founded in 2013 by Douglas E. Pierce, Jr..
DE
Douglas E. Pierce, Jr.Founder
JS
Joe SchmidtExecutive
ES
Edward S. SeguineExecutive
Board
AG
BG
Brad GeesamanBoard director
RK
Robert KniejskiBoard director
TF
MJ
Morana Jovan-EmbiricosBoard director
PR
Philip RS Waugh, Jr.Board director
Investors · 3
Reported raises · per SEC filings
Form D private placements$16.9M disclosed across 3 rounds · 2015–2018
▶$5.3MraisedMay 2018 · 5 investors · OtherRule 506(b)
▶$5.3MraisedMay 2018 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Matthew KingDirector
- Edward S. Seguine, Jr.Executive Officer, Director
- Richard MalcolmDirector
- Roger LaVern DavenportDirector
- Michael SorensenDirector
- Amount sold
- $5.3M
- Minimum investment
- $2.7K
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$1.7MraisedDec 2017 · 9 investors · OtherRule 506(b)
▶$1.7MraisedDec 2017 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Tony RosenbergDirector
- Phil WaughDirector
- Todd FoleyDirector
- Richard MalcolmDirector
- Scott MiltenbergerExecutive Officer
- Edward S. Seguine, Jr.Executive Officer, Director
- Matt KingDirector
- Offering amount
- $2.5M
- Amount sold
- $1.7M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$9.9MraisedApr 2015 · 21 investors · OtherRule 506(b)
▶$9.9MraisedApr 2015 · 21 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Ansbert GadickeDirector
- Matt KingDirector
- Joe SchmidtExecutive Officer
- Brad GeesamanDirector
- Robert KniejskiDirector
- Todd FoleyDirector
- Morana Jovan-EmbiricosDirector
- Philip RS Waugh, Jr.Director
- Douglas E. Pierce, Jr.Executive Officer, Director, Promoter
- Edward S. SeguineExecutive Officer, Director, Promoter
- Offering amount
- $9.9M
- Amount sold
- $9.9M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlap
IQVIA65 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Signant Health43 shared keywordsSignant Health provides eClinical technology and services for clinical trial data collection, including electronic data capture, patient and site data solutions, and scientific and operational support. It serves pharmaceutical sponsors and CROs running global clinical trials to generate high-quality data for trial decisions and regulatory submissions.
Medable41 shared keywordsMedable provides a cloud-based platform for clinical research that uses AI and digital tools to accelerate the development of therapies by improving the quality, reach, and efficiency of clinical trials. The platform serves pharmaceutical sponsors, contract research organizations (CROs), and clinical research sites.
Castor39 shared keywordsCastor provides an electronic data capture (EDC) platform for clinical trials and real-world evidence studies, combining eCOA/ePRO, eConsent, and clinical data management with AI-based extraction of source data into eCRFs. It serves biotech and pharma companies, medical device and diagnostics firms, contract research organizations, and academic researchers.
Medidata35 shared keywordsMedidata provides a cloud platform for clinical research that connects study, patient, and data workflows, including tools like Clinical Data Studio for data management, risk management, and medical review. It serves pharmaceutical and life sciences organizations running clinical trials, applying AI across the trial lifecycle.
Power33 shared keywordsPower builds a patient-friendly platform to discover and enroll in clinical trials, serving patients seeking access to research studies and researchers seeking to improve patient recruitment. The company operates in the healthcare technology and clinical research industry.
Companies competing with Clinical ink for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Clinical ink do?
- Digital data collection and clinical trial technology platform offering Direct Data Capture, eCOA, eConsent, and digital biomarkers.
- Who founded Clinical ink?
- Clinical ink was founded by Douglas E. Pierce, Jr. in 2013.
- Who are Clinical ink's investors?
- Clinical ink's investors include FCA Venture Partners, McKesson Ventures, MPM BioImpact.
- How much funding has Clinical ink raised?
- Clinical ink has disclosed $16.9M raised across 3 rounds.
- Where is Clinical ink headquartered?
- Clinical ink is headquartered in Winston-Salem, US.